78 results
Page 3 of 4
424B5
tbxu7v001nypygnv caa
9 Jan 20
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
z76wdfd6m gl
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
424B5
stpa8i
7 Jan 20
Prospectus supplement for primary offering
4:19pm
S-3ASR
EX-4.4
o45cz0zl
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
fi9kv8ln8akt0t
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.3
drn5l 0enbczuvbgy
7 Jan 20
Automatic shelf registration
4:01pm
8-K
EX-10.1
j4slrmqvac o2p0ak
7 Oct 19
Departure of Directors or Certain Officers
4:06pm
POS AM
EX-1.2
p731cq6 douoznyetf
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
POS AM
trfv6e3vwaaih9q gv
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
8-K
EX-4.1
fqu3xn6y8j 6tv15
16 Sep 19
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
5:17pm
424B5
ra5rvd6 h1v6qugw
7 Mar 19
Prospectus supplement for primary offering
4:28pm
8-K
EX-1.1
hbgdydh 2nwuvi7mszfw
7 Mar 19
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:15pm
424B5
q539esot6j9o6qrp
6 Mar 19
Prospectus supplement for primary offering
4:07pm
POS AM
5fsn12j cgl
26 Feb 19
Prospectus update (post-effective amendment)
4:47pm